The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function

Clinical Science

Volumn 116, Issue 4, 2009, Pages 301-314

  Qian, Cheng ^a   Schoemaker, Regien G ^a   van Gilst, Wiek H ^a   Roks, Anton J M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aldosterone; Angiotensin; Cardiovascular; Progenitor cell; Renin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR 1; ANGIOTENSIN RECEPTOR 2; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDAPAMIDE; IRBESARTAN; OLMESARTAN; PERINDOPRIL; RAMIPRIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERASPENIDE; UNCLASSIFIED DRUG; VALSARTAN; VASCULOTROPIN RECEPTOR; ANTIHYPERTENSIVE AGENT;

ADIPOCYTE; BONE MARROW CELL; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; CARDIOVASCULAR SYSTEM; CYTOLOGY; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 60549107875     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080157     Document Type: Review

References (112)

1. Rosamond, W., Flegal, K., Friday, G. et al. (2007) Heart disease and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115, e69-e171
2. Qian, C., Schoemaker, R. G., van Gilst, W. H., Yu, B. and Roks, A. J. M. (2008) Regenerative cell therapy and pharmacotherapeutic intervention in heart failure. Part I: cardiovascular progenitor cells, their functions and sources. Neth. Heart J. 16, 305-309
3. Assmus, B., Honold, J., Schachinger, V. et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232
4. Janssens, S., Dubois, C., Bogaert, J. et al. (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121
5. Schachinger, V., Erbs, S., Elsasser, A. et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221
6. Lunde, K., Solheim, S., Aakhus, S. et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199-1209
7. Haznedaroglu, I. C. and Ozturk, M. A. (2003) Towards the understanding of the local hematopoietic bone marrow renin - angiotensin system. Int. J. Biochem. Cell Biol. 35, 867-880
8. Hubert, C., Savary, K., Gasc, J. M. and Corvol, P. (2006) The hematopoietic system: a new niche for the renin - angiotensin system. Nat. Clin. Pract. Cardiovasc. Med. 3, 80-85
9. Vogeli, K. M., Jin, S. W., Martin, G. R. and Stainier, D. Y. (2006) A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 443, 337-339
10. Sainz, J., Al Haj Zen, A., Caligiuri, G. et al. (2006) Isolation of 'side population' progenitor cells from healthy arteries of adult mice. Arterioscler. Thromb. Vasc. Biol. 26, 281-286
11. Zengin, E., Chalajour, F., Gehling, U. M. et al. (2006) Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133, 1543-1551
12. Tillmanns, J., Rota, M., Hosoda, T. et al. (2008) Formation of large coronary arteries by cardiac progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 105, 1668-1673
13. Gonzalez, A., Rota, M., Nurzynska, D. et al. (2008) Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ. Res. 102, 597-606
14. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J. et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864
15. Aicher, A., Heeschen, C., Mildner-Rihm, C. et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376
16. Walter, D. H., Haendeler, J., Reinhold, J. et al. (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ. Res. 97, 1142-1151
17. + hemangiocytes. Nat. Med. 12, 557-567
18. Heissig, B., Hattori, K., Dias, S. et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637
19. Ferrario, C. M. (2006) Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 47, 515-521
20. Iusuf, D., Henning, R. H., van Gilst, W. H. and Roks, A. J. (2008) Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur. J. Pharmacol. 585, 303-312
21. Palardy, M., Ducharme, A. and O'Meara, E. (2007) Inhibiting the renin - angiotensin system with ACE inhibitors or ARBs after MI. Curr. Heart Failure Rep. 4, 190-197
22. Bahlmann, F. H., de Groot, K., Mueller, O., Hertel, B., Haller, H. and Fliser, D. (2005) Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45, 526-529
23. Yu, Y., Fukuda, N., Yao, E. H. et al. (2008) Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am. J. Hypertens. 21, 72-77
24. You, D., Cochain, C., Loinard, C. et al. (2008) Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 51, 1537-1544
25. Kobayashi, K., Imanishi, T. and Akasaka, T. (2006) Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model. Hypertens. Res. 29, 449-455
26. You, D., Cochain, C., Loinard, C. et al. (2008) Combination of the angiotensin converting enzyme inhibitor Perindopril and the diuretic Indapamide activate post-natal vasculogenesis in spontaneaously hypertensive rats. J. Pharmacol. Exp. Ther. 325, 766-773
27. Assmus, B., Urbich, C., Aicher, A. et al. (2003) HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res. 92, 1049-1055
28. Ben Porath, I. and Weinberg, R. A. (2005) The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37, 961-976
29. Freedman, D. A. and Folkman, J. (2005) CDK2 translational down-regulation during endothelial senescence. Exp. Cell Res. 307, 118-130
30. Fuster, J. J. and Andres, V. (2006) Telomere biology and cardiovascular disease. Circ. Res. 99, 1167-1180
31. Minamino, T. and Komuro, I. (2007) Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100, 15-26
32. Unterluggauer, H., Hampel, B., Zwerschke, W. and Jansen-Durr, P. (2003) Senescence-associated cell death of human endothelial cells: the role of oxidative stress. Exp. Gerontol. 38, 1149-1160
33. Imanishi, T., Hano, T. and Nishio, I. (2005) Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens. 23, 97-104
34. Herbert, K. E., Mistry, Y., Hastings, R., Poolman, T., Niklason, L. and Williams, B. (2008) Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ. Res. 102, 201-208
35. Min, L. J., Mogi, M., Iwanami, J. et al. (2008) Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition. Hypertension 51, 1339-1344
36. Hiasa, K., Ishibashi, M., Ohtani, K. et al. (2004) Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109, 2454-2461
37. Ohtani, K., Egashira, K., Ihara, Y. et al. (2006) Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension 48, 664-670
38. Imanishi, T., Hano, T. and Nishio, I. (2004) Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens. Res. 27, 101-108
39. Matsubara, K., Abe, E., Matsubara, Y., Kameda, K. and Ito, M. (2006) Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am. J. Reprod. Immunol. 56, 79-85
40. Salguero, G., Akin, E., Templin, C. et al. (2008) Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J. Hypertens. 26, 257-268
41. Benndorf, R. A., Appel, D., Maas, R., Schwedhelm, E., Wenzel, U. O. and Boger, R. H. (2007) Telmisartan improves endothelial function in patients with essential hypertension. J. Cardiovasc. Pharmacol. 50, 367-371
42. Werner, N., Kosiol, S., Schiegl, T. et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007
43. Steiner, S., Winkelmayer, W. C., Kleinert, J. et al. (2006) Endothelial progenitor cells in kidney transplant recipients. Transplantation 81, 599-606
44. Mai, M., Hilgers, K. F., Wagner, J., Mann, J. F. and Geiger, H. (1995) Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney. Hypertension 25, 674-678
45. Sowers, J. R. (2002) Hypertension, angiotensin II, and oxidative stress. N. Engl. J. Med. 346, 1999-2001
46. Shibota, M., Nagaoka, A., Shino, A. and Fujita, T. (1979) Renin - angiotensin system in stroke-prone spontaneously hypertensive rats. Am. J. Physiol. 236, H409-H416
47. Campbell, D. J., Duncan, A. M., Kladis, A. and Harrap, S. B. (1995) Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 25, 928-934
48. Benndorf, R., Boger, R. H., Ergun, S., Steenpass, A. and Wieland, T. (2003) Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ. Res. 93, 438-447
49. Fulton, D., Gratton, J. P., McCabe, T. J. et al. (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601
50. Silvestre, J. S., Tamarat, R., Senbonmatsu, T. et al. (2002) Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 90, 1072-1079
51. Guo, W. X., Yang, Q. D., Liu, Y. H., Xie, X. Y., Wang, M. and Niu, R. C. (2008) Palmitic and linoleic acids impair endothelial progenitor cells by inhibition of Akt/eNOS pathway. Arch. Med. Res. 39, 434-442
52. Yamada, T., Kondo, T., Numaguchi, Y. et al. (2007) Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler. Thromb. Vasc. Biol. 27, 2363-2369
53. Matsushita, K., Wu, Y., Okamoto, Y., Pratt, R. E. and Dzau, V. J. (2006) Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48, 1095-1102
54. Mogi, M., Iwai, M. and Horiuchi, M. (2006) Emerging concept of adipogenesis regulation by the renin-angiotensin system. Hypertension 48, 1020-1022
55. Marumo, T., Uchimura, H., Hayashi, M., Hishikawa, K. and Fujita, T. (2006) Aldosterone impairs bone marrow-derived progenitor cell formation. Hypertension 48, 490-496
56. Verhovez, A., Zeoli, A., Williams, T. A. et al. (2008) Primary aldosteronism and endothelial progenitor cell bioavailability. Clin. Endocrinol. 69, 528-534
57. Mancini, G. B., Henry, G. C., Macaya, C. et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94, 258-265
58. Rauscher, F. M., Goldschmidt-Clermont, P. J., Davis, B. H. et al. (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-463
59. Vasa, M., Fichtlscherer, S., Aicher, A. et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, e1-e7
60. Hill, J. M., Zalos, G., Halcox, J. P. et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600
61. Silvestre, J. S., Bergaya, S., Tamarat, R., Duriez, M., Boulanger, C. M. and Levy, B. I. (2001) Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ. Res. 89, 678-683
62. Min, T. Q., Zhu, C. J., Xiang, W. X., Hui, Z. J. and Peng, S. Y. (2004) Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 18, 203-209
63. Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B. and Gavras, H. (1982) Antihypertensive therapy with MK 421: angiotensin II - renin relationships to evaluate efficacy of converting enzyme blockade. J. Cardiovasc. Pharmacol. 4, 966-972
64. Juillerat, L., Nussberger, J., Menard, J. et al. (1990) Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 16, 564-572
65. van de Wal, R. M., Plokker, H. W., Lok, D. J. et al. (2006) Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int. J. Cardiol. 106, 367-372
66. Boyle, A. J., Schuster, M., Witkowski, P. et al. (2005) Additive effects of endothelial progenitor cells combined with ACE inhibition and β-blockade on left ventricular function following acute myocardial infarction. J. Renin Angiotensin Aldosterone Syst. 6, 33-37
67. Olivares, E. L., Costa-E-Sousa, R. H., Werneck-de-Castro, J. P. et al. (2007) Cellular cardiomyoplasty in large myocardial infarction: can the beneficial effect be enhanced by ACE-inhibitor therapy? Eur. J. Heart Failure 9, 558-567
68. Wang, C. H., Verma, S., Hsieh, I. C. et al. (2006) Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J. Mol. Cell. Cardiol. 41, 34-43
69. Thum, T., Fraccarollo, D., Galuppo, P. et al. (2006) Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc. Res. 70, 50-60
70. Volpert, O. V., Ward, W. F., Lingen, M. W. et al. (1996) Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest. 98, 671-679
71. van de Wal, R. M., van der Harst, P., Gerritsen, W. B. et al. (2007) Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects. J. Renin Angiotensin Aldosterone Syst. 8, 177-180
72. Ebihara, I., Nakamura, T., Shimada, N. and Koide, H. (1998) Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am. J. Kidney Dis. 32, 544-550
73. Wang, Q. R., Wang, B. H., Huang, Y. H., Dai, G., Li, W. M. and Yan, Q. (2008) Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells. J. Cell. Biochem. 103, 21-29
74. Sharma, U., Rhaleb, N. E., Pokharel, S. et al. (2008) Novel anti-inflammatory mechanisms of N-acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am. J. Physiol. Heart Circ. Physiol. 294, H1226-H1232
75. Pokharel, S., van Geel, P. P., Sharma, U. C. et al. (2004) Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3. Circulation 110, 3129-3135
76. Liu, J. M., Lawrence, F., Kovacevic, M. et al. (2003) The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 101, 3014-3020
77. Wang, D., Carretero, O. A., Yang, X. Y. et al. (2004) N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo. Am. J. Physiol. Heart Circ. Physiol. 287, H2099-H2105
78. Duncan, A. M., Burrell, L. M., Kladis, A. and Campbell, D. J. (1996) Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J. Cardiovasc. Pharmacol. 28, 746-754
79. Campbell, D. J., Alexiou, T., Xiao, H. D. et al. (2004) Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43, 854-859
80. Thuringer, D., Maulon, L. and Frelin, C. (2002) Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J. Biol. Chem. 277, 2028-2032
81. Miura, S., Matsuo, Y. and Saku, K. (2003) Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 41, 1118-1123
82. Rice, G. I., Thomas, D. A., Grant, P. J., Turner, A. J. and Hooper, N. M. (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 383, 45-51
83. Chappell, M. C., Pirro, N. T., Sykes, A. and Ferrario, C. M. (1998) Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31, 362-367
84. Campbell, D. J., Kladis, A. and Duncan, A. M. (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23, 439-449
85. Roks, A. J. M., van Geel, P. P., Pinto, Y. M. et al. (1999) Angiotensin-(1-7) is a modulator of the human renin - angiotensin system. Hypertension 34, 296-301
86. Rowe, B. P., Saylor, D. L., Speth, R. C. and Absher, D. R. (1995) Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain. Regul. Pept. 56, 139-146
87. Garcia, N. H. and Garvin, J. L. (1994) Angiotensin-(1-7) has a biphasic effect on fluid absorption in the proximal straight tubule. J. Am. Soc. Nephrol. 5, 1133-1138
88. Vallon, V., Heyne, N., Richter, K., Khosla, M. C. and Fechter, K. (1998) [7-[s D s]-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat. J. Cardiovasc. Pharmacol. 32, 164-167
89. Clark, M. A., Diz, D. I. and Tallant, E. A. (2001) Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37, 1141-1146
90. Clark, M. A., Tallant, E. A. and Diz, D. I. (2001) Downregulation of the AT1A receptor by pharmacologic concentrations of angiotensin-(1-7). J. Cardiovasc. Pharmacol. 37, 437-448
91. Zhu, Z., Zhong, J., Zhu, S., Liu, D., Van Der Giet, M. and Tepel, M. (2002) Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction. J. Cardiovasc. Pharmacol. 40, 693-700
92. Santos, R. A., Simoes e Silva, A. C., Maric, C. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263
93. Iyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I. and Ferrario, C. M. (1998) Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31, 699-705
94. Iyer, S. N., Yamada, K., Diz, D. I., Ferrario, C. M. and Chappell, M. C. (2000) Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J. Cardiovasc. Pharmacol. 36, 109-117
95. Collister, J. P. and Hendel, M. D. (2003) The role of Ang-(1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J. Renin Angiotensin Aldosterone Syst. 4, 176-179
96. Loot, A. E., Roks, A. J., Henning, R. H. et al. (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105, 1548-1550
97. Langeveld, B., van Gilst, W. H., Tio, R. A., Zijlstra, F. and Roks, A. J. (2005) Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. Hypertension 45, 138-141
98. Rodgers, K. E., Xiong, S. and diZerega, G. S. (2002) Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother. Pharmacol. 49, 403-411
99. Rodgers, K. E., Oliver, J. and diZerega, G. S. (2006) Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother. Pharmacol. 57, 559-568
100. Ellefson, D. D., diZerega, G. S., Espinoza, T., Roda, N., Maldonado, S. and Rodgers, K. E. (2004) Synergistic effects of co-administration of angiotensin 1-7 and neupogen on hematopoietic recovery in mice. Cancer Chemother. Pharmacol. 53, 15-24
101. Peiro, C., Vallejo, S., Gembardt, F. et al. (2007) Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J. Hypertens. 25, 2421-2425
102. Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49, 185-192
103. Sampaio, W. O., Henrique de Castro, C., Santos, R. A., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50, 1093-1098
104. Nelissen-Vrancken, H. J., Debets, J. J., Snoeckx, L. H., Daemen, M. J. and Smits, J. F. (1996) Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 93, 349-355
105. Machado, R. D., Santos, R. A. and Andrade, S. P. (2001) Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R994-R1000
106. Anton, L., Merrill, D. C., Neves, L. A. and Brosnihan, K. B. (2007) Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 32, 212-218
107. Rodgers, K. E., Roda, N., Felix, J. E., Espinoza, T., Maldonado, S. and diZerega, G. (2003) Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice. Exp. Dermatol. 12, 784-790
108. van Beusekom, H. M., Schoemaker, R., Roks, A. J., Zijlstra, F. and van der Giessen, W. J. (2007) Coronary stent healing, endothelialisation and the role of co-medication. Neth. Heart J. 15, 395-396
109. Fabre, J. E., Rivard, A., Magner, M., Silver, M. and Isner, J. M. (1999) Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 99, 3043-3049
110. Xu, S. Q., Mahadev, K., Wu, X. et al. (2008) Adiponectin protects against angiotensin II or tumor necrosis factor α-induced endothelial cell monolayer hyperpermeability: role of cAMP/PKA signaling. Arterioscler. Thromb. Vasc. Biol. 28, 899-905
111. Mehta, D. and Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367
112. Santos, R. A., Frezard, F. and Ferreira, A. J. (2005) Angiotensin-(1-7): blood, heart, and blood vessels. Curr. Med. Chem. Cardiovasc. Hematol. Agents 3, 383-391